Genomic studies have shown that there are elevated mutation rates in active transcription factor (TF) binding sites in several tumor types2–8, with the trend being most prominent in melanomas, which are linked to ultraviolet (UV) light exposure5–7,9,10. The gene discussed is TF; the disease is melanoma.